Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 235 citing articles:

The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19
Harsh Shah, Md Shahjalal Hossain Khan, Nikhil V. Dhurandhar, et al.
Acta Diabetologica (2021) Vol. 58, Iss. 7, pp. 831-843
Open Access | Times Cited: 70
SARS-CoV-2 disease severity and diabetes: why the connection and what is to be done?
Caio Henrique Mazucanti, Josephine M. Egan
Immunity & Ageing (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 69
Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management
Shreya R. Savla, Kedar S. Prabhavalkar, Lokesh Kumar Bhatt
Expert Review of Anti-infective Therapy (2021) Vol. 19, Iss. 11, pp. 1397-1413
Open Access | Times Cited: 69
Endothelial cells and SARS-CoV-2: An intimate relationship
Lucas Cunha Barbosa, Thaynan Lopes Gonçalves, Luanna Prudencio de Araújo, et al.
Vascular Pharmacology (2021) Vol. 137, pp. 106829-106829
Open Access | Times Cited: 66
Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System
Jacob Roberts, Antonia L. Pritchard, Andrew T. Treweeke, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 7
Open Access | Times Cited: 60
White Blood Cells and Severe COVID-19: A Mendelian Randomization Study
Yitang Sun, Jingqi Zhou, Kaixiong Ye
Journal of Personalized Medicine (2021) Vol. 11, Iss. 3, pp. 195-195
Open Access | Times Cited: 59
Type-2 Diabetes as a Risk Factor for Severe COVID-19 Infection
Mahnaz Norouzi, Shaghayegh Norouzi, Alistaire D. Ruggiero, et al.
Microorganisms (2021) Vol. 9, Iss. 6, pp. 1211-1211
Open Access | Times Cited: 58
Next-Generation Sequencing Reveals the Progression of COVID-19
Xiaohong Chen, Yutong Kang, Jing Luo, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 57
Mechanisms of COVID-19 pathogenesis in diabetes
Chandrakala Aluganti Narasimhulu, Dinender K. Singla
AJP Heart and Circulatory Physiology (2022) Vol. 323, Iss. 3, pp. H403-H420
Open Access | Times Cited: 42
Mechanisms contributing to adverse outcomes of COVID-19 in obesity
Manu Sudhakar, Sofi Beaula Winfred, Gowri Meiyazhagan, et al.
Molecular and Cellular Biochemistry (2022) Vol. 477, Iss. 4, pp. 1155-1193
Open Access | Times Cited: 37
Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection
Peiran Chen, Mandi Wu, Yaqing He, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 27
COVID-19: Diabetes Perspective—Pathophysiology and Management
Siva Dallavalasa, SubbaRao V. Tulimilli, Prakash Janhavi, et al.
Pathogens (2023) Vol. 12, Iss. 2, pp. 184-184
Open Access | Times Cited: 23
Expression of ACE2, the SARS-CoV-2 Receptor, in Lung Tissue of Patients With Type 2 Diabetes
Sara Wijnant, Merel Jacobs, Hannelore P. Van Eeckhoutte, et al.
Diabetes (2020) Vol. 69, Iss. 12, pp. 2691-2699
Open Access | Times Cited: 60
Outbreak of SARS-CoV2: Pathogenesis of infection and cardiovascular involvement
Hamideh Amirfakhryan, Fatemeh Safari
Hellenic Journal of Cardiology (2020) Vol. 62, Iss. 1, pp. 13-23
Open Access | Times Cited: 56
The Efficacy and Potential Mechanisms of Metformin in the Treatment of COVID-19 in the Diabetics: A Systematic Review
Moein Zangiabadian, Seyed Aria Nejadghaderi, Mohammad Mahdi Zahmatkesh, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 53
Diabetes Mellitus and COVID-19: Associations and Possible Mechanisms
Gerui Li, Ze Chen, Zhan Lv, et al.
International Journal of Endocrinology (2021) Vol. 2021, pp. 1-10
Open Access | Times Cited: 53
Metformin to decrease COVID-19 severity and mortality: Molecular mechanisms and therapeutic potential
Oleksandr Kamyshnyi, V. M. Matskevych, Tetyana Lenchuk, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 144, pp. 112230-112230
Open Access | Times Cited: 53
Age-Related Differences in Immunological Responses to SARS-CoV-2
Lydia Su Yin Wong, Evelyn Xiu Ling Loo, Alicia Kang, et al.
The Journal of Allergy and Clinical Immunology In Practice (2020) Vol. 8, Iss. 10, pp. 3251-3258
Open Access | Times Cited: 52
Obesity, Diabetes and COVID-19: An Infectious Disease Spreading From the East Collides With the Consequences of an Unhealthy Western Lifestyle
Jeff M.P. Holly, Kalina Biernacka, Nick Maskell, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 52
Clinical Management of Diabetes Mellitus in the Era of COVID-19: Practical Issues, Peculiarities and Concerns
Chrysi Koliaki, Anastasios Tentolouris, Ioanna Eleftheriadou, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 7, pp. 2288-2288
Open Access | Times Cited: 51
Factors Associated with Increased Morbidity and Mortality of Obese and Overweight COVID-19 Patients
Amany Magdy Beshbishy, ‏Helal F. Hetta, Diaa E. Hussein, et al.
Biology (2020) Vol. 9, Iss. 9, pp. 280-280
Open Access | Times Cited: 51
DeepDRIM: a deep neural network to reconstruct cell-type-specific gene regulatory network using single-cell RNA-seq data
Jiaxing Chen, ChinWang Cheong, Liang Lan, et al.
Briefings in Bioinformatics (2021) Vol. 22, Iss. 6
Open Access | Times Cited: 49
COVID‐19 infection, progression, and vaccination: Focus on obesity and related metabolic disturbances
Annemarie J. F. Westheim, Albert V. Bitorina, Jan Theys, et al.
Obesity Reviews (2021) Vol. 22, Iss. 10
Open Access | Times Cited: 40
Diabetes increases the risk of COVID-19 in an altitude dependent manner: An analysis of 1,280,806 Mexican patients
Juan Alonso León-Abarca, Arianna Portmann-Baracco, Mayte Bryce‐Alberti, et al.
PLoS ONE (2021) Vol. 16, Iss. 8, pp. e0255144-e0255144
Open Access | Times Cited: 40
The Interaction Between Pulmonary Fibrosis and COVID-19 and the Application of Related Anti-Fibrotic Drugs
Hao Shen, Nu Zhang, Yuqing Liu, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 32

Scroll to top